We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Efficacy and Safety of Olanzapine in Patients With Borderline Personality Disorder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00088036
Recruitment Status : Completed
First Posted : July 21, 2004
Last Update Posted : July 24, 2006
Information provided by:
Eli Lilly and Company